This is a preview of subscription content, log in via an institution to check access.
Reference
Vijenthira A, et al. Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy. Bone Marrow Transplantation : 13 May 2021. Available from: URL: http://doi.org/10.1038/s41409-021-01327-5
Rights and permissions
About this article
Cite this article
Autologous stem-cell transplant for early relapse of follicular lymphoma: better outcomes, lower cost. PharmacoEcon Outcomes News 879, 5 (2021). https://doi.org/10.1007/s40274-021-7728-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7728-6